MarketCap
Facebook
X
Telegram
REGENXBIO PEG Ratio | RGNX
Annual PEG Ratio REGENXBIO
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0212 | 0.0178 | 0.0222 | 0.0179 | -0.0612 | 0.143 | 0.0922 | 0.0647 | 3.92 | -0.939 | 0.0161 | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.92 | -0.939 | 0.302 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Rafael Holdings
RFL
|
-0.0215 | $ 1.02 | -4.67 % | $ 52.4 M |  USA |
 |
Rigel Pharmaceuticals
RIGL
|
0.00182 | $ 39.52 | -13.54 % | $ 711 M | USA |
 |
Celsion Corporation
CLSN
|
-0.000473 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
0.0579 | - | - | $ 866 M |  China |
 |
Tenax Therapeutics
TENX
|
-0.00225 | $ 1.68 | 3.07 % | $ 65.9 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Scholar Rock Holding Corporation
SRRK
|
-2 | $ 46.77 | 2.78 % | $ 5.36 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M |  Germany |
 |
Spero Therapeutics
SPRO
|
-0.1 | $ 1.03 | 1.47 % | $ 57.7 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M |  Israel |
 |
Rezolute
RZLT
|
0.272 | $ 3.85 | 5.77 % | $ 400 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.73 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
-0.408 | $ 0.69 | 11.43 % | $ 73.6 M | Britain |
 |
MorphoSys AG
MOR
|
0.00558 | - | 2.43 % | $ 254 M | Germany |
 |
Affimed N.V.
AFMD
|
3.06 | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
0.17 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
0.0181 | - | - | $ 12.5 M |  Belgium |
 |
Seer
SEER
|
0.177 | $ 1.63 | 0.18 % | $ 90.4 M | USA |
 |
Gracell Biotechnologies
GRCL
|
-0.448 | - | - | $ 3.37 B | China |
 |
Stoke Therapeutics
STOK
|
28.1 | $ 26.51 | 1.69 % | $ 1.57 B | USA |
 |
Sutro Biopharma
STRO
|
-0.00235 | $ 9.57 | 4.08 % | $ 81.3 M | USA |
|
Silence Therapeutics plc
SLN
|
-1.66 | $ 19.73 | 0.03 % | $ 2.8 B | Britain |
 |
Taysha Gene Therapies
TSHA
|
0.536 | $ 4.34 | 6.11 % | $ 1.39 B | USA |
 |
Soligenix
SNGX
|
-0.00382 | $ 0.34 | 0.54 % | $ 1.76 M | USA |
 |
Spruce Biosciences
SPRB
|
-0.000824 | $ 46.46 | 8.78 % | $ 35.6 M | USA |
 |
Supernus Pharmaceuticals
SUPN
|
8 | $ 26.14 | -2.24 % | $ 1.48 B | USA |
 |
Galapagos NV
GLPG
|
-0.132 | - | - | $ 1.83 B | Belgium |
 |
Savara
SVRA
|
-3.3 | $ 4.82 | 9.93 % | $ 1.07 B | USA |
 |
Viking Therapeutics
VKTX
|
-0.000329 | $ 26.86 | 4.15 % | $ 3.03 B | USA |
 |
Teligent, Inc.
TLGT
|
-0.0285 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
0.0381 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
0.325 | $ 59.78 | 3.1 % | $ 8.63 B | USA |
 |
Aphria Inc.
APHA
|
-0.0341 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-0.181 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
0.0792 | - | -6.00 % | $ 238 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
1.89 | $ 3.37 | 4.66 % | $ 568 M |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-0.0627 | - | - | $ 376 M | USA |
 |
AzurRx BioPharma, Inc.
AZRX
|
0 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
0.0175 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
0.26 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
0.0402 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-1.09 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
5.81 | - | 1.3 % | $ 27.7 M | France |
 |
GW Pharmaceuticals plc
GWPH
|
-0.151 | - | - | $ 6.81 B | Britain |